	Zysk Brutto Na Sprzedaży		Data
Acadia Pharmaceuticals	USD 257.76M	778K	2025-12
Agios Pharmaceuticals	USD 18.09M	6.89M	2025-12
Akebia Therapeutics	USD 49.21M	13.25M	2025-03
Almirall	EUR 429.87M	180.02M	2025-12
Alnylam Pharmaceuticals	USD 829.31M	219.56M	2025-12
Amarin	USD 22.21M	28.15M	2025-09
Ardelyx	USD 106.35M	23.51M	2025-09
Astellas Pharma	JPY 456.81B	38.02B	2025-12
AstraZeneca	USD 12.39B	5M	2025-12
Charles River Laboratories	USD 271.96M	39.43M	2025-12
Coherus Biosciences	USD 4.95M	15.34M	2025-03
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Exact Sciences	USD 583.93M	21.48M	2025-09
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Incyte	USD 1.39B	118.68M	2025-12
Ironwood Pharmaceuticals	USD 85.24M	44.1M	2025-06
Karyopharm Therapeutics	USD -30.78M	1.29M	2024-12
Lexicon Pharmaceuticals	USD -16.16M	2.89M	2024-06
MacroGenics	USD 61.25M	88.71M	2025-09
Moderna	USD 226M	583M	2025-12
Myriad Genetics	USD 143.8M	8M	2025-09
Pacira	USD 142.25M	11.34M	2025-12
PTC Therapeutics	USD 148.38M	39.31M	2025-12
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Sarepta Therapeutics	USD 43.55M	204.36M	2025-12
Takeda	JPY 790.55B	262.97B	2025-12
Ultragenyx Pharmaceutical	USD 178M	46.06M	2025-12
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12

Ironwood Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.